{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Small-Dose Intravenous Ketamine with Continuous Femoral Nerve Block in Total Knee Arthroplasty"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "In a randomised controlled trial, patients undergoing total knee arthroplasty were randomly assigned to receive either an initial bolus of 0.5 mg/kg ketamine followed by a continuous infusion of 3 \u03bcg\u00b7kg -1 \u00b7min -1 during surgery and 1.5 \u03bcg\u00b7kg -1 \u00b7min -1 for 48 h (Ketamine group) or an equal volume of saline (Control group)."
      },
      "Participants": {
        "score": 1,
        "evidence": "patients undergoing total knee arthroplasty"
      },
      "Intervention": {
        "score": 2,
        "evidence": "patients undergoing total knee arthroplasty were randomly assigned to receive either an initial bolus of 0.5 mg/kg ketamine followed by a continuous infusion of 3 \u03bcg\u00b7kg -1 \u00b7min -1 during surgery and 1.5 \u03bcg\u00b7kg -1 \u00b7min -1 for 48 h (Ketamine group) or an equal volume of saline (Control group)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluated the effect of small-dose intravenous ketamine combined with continuous femoral nerve block on postoperative pain and rehabilitation after total knee arthroplasty."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was morphine consumption over 48 hours."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence with allocation concealment."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Patients, clinicians, and outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 200 participants were randomised: 100 to the Ketamine group and 100 to the Control group."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The Ketamine group required significantly less morphine than the Control group (45 \u00b1 20 mg versus 69 \u00b1 30 mg; P < 0.02)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Adverse events were not reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]."
      }
    },
    "total_score": 17,
    "max_score": 25
  },
  "model": "gpt-4o"
}